Chad M Robins - Net Worth and Insider Trading

Chad M Robins Net Worth

The estimated net worth of Chad M Robins is at least $7 Million dollars as of 2024-04-26. Chad M Robins is the CEO and Chairman of Adaptive Biotechnologies Corp and owns about 2,576,701 shares of Adaptive Biotechnologies Corp (ADPT) stock worth over $7 Million. Details can be seen in Chad M Robins's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Chad M Robins has not made any transactions after 2024-03-05 and currently still holds the listed stock(s).

Transaction Summary of Chad M Robins

To

Chad M Robins Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Chad M Robins owns 4 companies in total, including Adaptive Biotechnologies Corp (ADPT) , ARYA Sciences Acquisition Corp II (ARYBU) , and Cerevel Therapeutics Holdings Inc (CERE) among others .

Click here to see the complete history of Chad M Robins’s form 4 insider trades.

Insider Ownership Summary of Chad M Robins

Ticker Comapny Transaction Date Type of Owner
ADPT Adaptive Biotechnologies Corp 2024-03-05 director & CEO and Chairman
ARYBU ARYA Sciences Acquisition Corp II 2020-06-04 director
CERE Cerevel Therapeutics Holdings Inc 2020-06-04 director
EQRX EQRx Inc 2021-04-06 director

Chad M Robins Latest Holdings Summary

Chad M Robins currently owns a total of 1 stock. Chad M Robins owns 2,576,701 shares of Adaptive Biotechnologies Corp (ADPT) as of March 5, 2024, with a value of $7 Million.

Latest Holdings of Chad M Robins

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ADPT Adaptive Biotechnologies Corp 2024-03-05 2,576,701 2.61 6,725,190

Holding Weightings of Chad M Robins


Chad M Robins Form 4 Trading Tracker

According to the SEC Form 4 filings, Chad M Robins has made a total of 27 transactions in Adaptive Biotechnologies Corp (ADPT) over the past 5 years, including 0 buys and 27 sells. The most-recent trade in Adaptive Biotechnologies Corp is the sale of 48,673 shares on March 5, 2024, which brought Chad M Robins around $166,948.

Insider Trading History of Chad M Robins

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Chad M Robins Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Chad M Robins Ownership Network

Ownership Network List of Chad M Robins

No Data

Ownership Network Relation of Chad M Robins


Chad M Robins Owned Company Details

What does Adaptive Biotechnologies Corp do?

Who are the key executives at Adaptive Biotechnologies Corp?

Chad M Robins is the director & CEO and Chairman of Adaptive Biotechnologies Corp. Other key executives at Adaptive Biotechnologies Corp include Chief Commercial Ofc Imm Med Sharon Benzeno , Chief Financial Officer Tycho Peterson , and Principal Accounting Officer Kyle Piskel .

Adaptive Biotechnologies Corp (ADPT) Insider Trades Summary

Over the past 18 months, Chad M Robins made 1 insider transaction in Adaptive Biotechnologies Corp (ADPT) with a net sale of 48,673. Other recent insider transactions involving Adaptive Biotechnologies Corp (ADPT) include a net sale of 12,781 shares made by Kyle Piskel , a net sale of 258,417 shares made by Tycho Peterson , and a net sale of 63,742 shares made by Nitin Sood .

In summary, during the past 3 months, insiders sold 181,388 shares of Adaptive Biotechnologies Corp (ADPT) in total and bought 0 shares, with a net sale of 181,388 shares. During the past 18 months, 585,531 shares of Adaptive Biotechnologies Corp (ADPT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 585,531 shares.

Adaptive Biotechnologies Corp (ADPT)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Adaptive Biotechnologies Corp Insider Transactions

No Available Data

Chad M Robins Mailing Address

Above is the net worth, insider trading, and ownership report for Chad M Robins. You might contact Chad M Robins via mailing address: C/o Adaptive Biotechnologies Corporation, 1551 Eastlake Ave E Ste 200, Seattle Wa 98102.

Discussions on Chad M Robins

No discussions yet.